Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
Sarepta Therapeutics Inc (SRPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and Strategic Advances
Q1 2024 Sarepta Therapeutics Inc Earnings Call Transcript
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
Viking (VKTX) to Report Q1 Earnings: What's in the Cards?
Should iShares Morningstar Small-Cap ETF (ISCB) Be on Your Investing Radar?
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
Sarepta Therapeutics' (NASDAQ:SRPT) growing losses don't faze investors as the stock increases 3.6% this past week
Should iShares Morningstar Small-Cap Growth ETF (ISCG) Be on Your Investing Radar?
US FDA approves Italfarmaco's drug for Duchenne muscle-wasting disorder
Director Wigzell Hans Lennart Rudolf Sells 15,000 Shares of Sarepta Therapeutics Inc (SRPT)
Director Stephen Mayo Sells 3,135 Shares of Sarepta Therapeutics Inc (SRPT)
REGENXBIO (RGNX) Soars 15% on Interim Data From DMD Study
Morgan Stanley says M&A will rebound and these stocks have an 'elevated likelihood' of a takeover
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
Sarepta Therapeutics to Present at Upcoming Investor Conferences
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.